Jonathan W Engle Selected Research

Jonathan W Engle Research Topics

Disease

71	Neoplasms (Cancer) 04/2024 - 07/2011
10	Breast Neoplasms (Breast Cancer) 01/2024 - 03/2012
7	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 01/2018
6	Reperfusion Injury 09/2022 - 10/2019
5	Lymphoma (Lymphomas) 01/2023 - 01/2018
5	Melanoma (Melanoma, Malignant) 01/2021 - 05/2019
4	Lung Neoplasms (Lung Cancer) 04/2024 - 10/2017
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 11/2012
4	Acute Kidney Injury (Acute Renal Failure) 06/2020 - 11/2018
4	Neoplasm Metastasis (Metastasis) 01/2020 - 08/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 10/2017
3	Triple Negative Breast Neoplasms 01/2024 - 11/2019
3	Adenocarcinoma 03/2023 - 01/2021
3	Brain Ischemia (Cerebral Ischemia) 09/2022 - 10/2019
3	Glioblastoma (Glioblastoma Multiforme) 04/2012 - 09/2011
2	Thyroid Neoplasms (Thyroid Cancer) 11/2020 - 07/2020
2	Anaplastic Thyroid Carcinoma 11/2020 - 07/2020
2	Rhabdomyolysis 06/2020 - 11/2018
1	Fibrosis (Cirrhosis) 04/2024
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 04/2024
1	Lung Injury 04/2024
1	Lung Diseases (Lung Disease) 04/2024
1	Circulating Neoplastic Cells 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Neuroinflammatory Diseases 12/2021
1	Inflammation (Inflammations) 04/2021

Drug/Important Bio-Agent (IBA)

17	Monoclonal AntibodiesIBA 01/2024 - 01/2012
14	Radioisotopes (Radionuclides)IBA 01/2022 - 05/2015
7	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 04/2024 - 08/2011
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2017
6	AntioxidantsIBA 04/2021 - 11/2018
5	Peptides (Polypeptides)IBA 04/2024 - 01/2012
5	Immunoglobulin G (IgG)IBA 01/2024 - 01/2018
5	Chelating AgentsIBA 09/2018 - 05/2015
4	RadiopharmaceuticalsIBA 02/2024 - 12/2018
4	PolymersIBA 08/2023 - 01/2017
4	daratumumabIBA 01/2022 - 01/2018
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 12/2018
4	carotuximabIBA 01/2018 - 03/2012
4	EndoglinIBA 03/2012 - 07/2011
3	LigandsIBA 04/2024 - 01/2012
3	IsotopesIBA 03/2024 - 08/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2012
3	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021 - 01/2018
3	Thromboplastin (Tissue Factor)IBA 07/2020 - 11/2012
3	PorphyrinsIBA 12/2019 - 01/2018
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2019 - 01/2018
2	Photosensitizing Agents (Photosensitizers)IBA 08/2023 - 11/2018
2	Neurotensin Receptors (Neurotensin Receptor)IBA 03/2023 - 12/2022
2	Surface Antigens (Surface Antigen)IBA 01/2023 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2011
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2021 - 11/2020
2	Surface-Active Agents (Surfactants)IBA 01/2021 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
2	Deferoxamine (Desferal)FDA LinkGeneric 12/2019 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 03/2019 - 11/2018
2	MicellesIBA 01/2019 - 04/2012
2	IRDye 800CWIBA 01/2019 - 08/2012
2	manganese oxide (hausmannite)IBA 05/2018 - 11/2017
2	HydrazonesIBA 04/2012 - 01/2012
2	IntegrinsIBA 04/2012 - 09/2011
2	AcidsIBA 01/2012 - 08/2011
1	Bleomycin (Blenoxane)FDA LinkGeneric 04/2024
1	Death Domain ReceptorsIBA 04/2024
1	Single-Domain AntibodiesIBA 03/2024
1	Proto-Oncogene Proteins c-metIBA 03/2024
1	SiderophoresIBA 03/2024
1	EnterobactinIBA 03/2024
1	AntigensIBA 03/2024
1	durvalumabIBA 01/2024
1	Cobalt-55IBA 10/2023
1	NeurotensinIBA 03/2023
1	lysylprolineIBA 03/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	Epithelial Cell Adhesion MoleculeIBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	Androgen Receptors (Androgen Receptor)IBA 01/2023
1	glabridinIBA 09/2022
1	Glutathione (Reduced Glutathione)IBA 04/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Staphylococcal Protein A (Protein A)IBA 12/2021
1	AlloysIBA 06/2021
1	APTIBA 04/2021
1	ceric oxide (cerium dioxide)IBA 04/2021
1	Yttrium-86IBA 01/2021

Therapy/Procedure

27	Therapeutics 04/2024 - 02/2011
17	Precision Medicine 10/2023 - 04/2012
9	Radiotherapy 01/2022 - 01/2017
4	Immunotherapy 04/2024 - 05/2019
4	Photothermal Therapy 06/2021 - 01/2012
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2012
2	Computer-Assisted Surgery (Image Guided Surgery) 01/2021 - 01/2019
2	Radioimmunotherapy 01/2021 - 07/2020
2	Spinal Injections 02/2020 - 10/2019
2	Intravenous Injections 01/2020 - 01/2017
2	Photochemotherapy (Photodynamic Therapy) 01/2019 - 11/2018
2	Lasers (Laser) 01/2018 - 08/2017
1	Off-Label Use 03/2024
1	Castration 01/2023
1	Intravenous Administration 01/2022